Financials
- Market Capitalization 2.03 B
- Employee 104
- Founded 2005
- CEO N/A
- Website www.anaptysbio.com
- Headquarter Delaware, United States
- FIGI BBG0026ZDHR0
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1965 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.03 USD | +1.58% | +3.42% | +0.63% | +34.37% | 2.06 B USD | ||
| 1966 | HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 35.54 USD | -3.53% | -5.07% | +3.95% | +15.02% | 2.06 B USD | ||
| 1979 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 22.89 USD | -3.05% | +2.28% | +25.63% | +131.21% | 2.03 B USD | ||
| 1987 | NUVB Nuvation Bio Inc. Class A Common Stock | 5.76 USD | -0.86% | +1.41% | +14.51% | +164.22% | 2.01 B USD |
Frequently asked questions about AnaptysBio, Inc. - Common Stock
What is the AnaptysBio, Inc. - Common Stock stock price today?
The current price of AnaptysBio, Inc. - Common Stock (ANAB) is 69.81. Over the past 24 hours, the stock has changed by +5.15%. Follow the ANAB chart for real-time price dynamics.
What is the stock ticker of AnaptysBio, Inc. - Common Stock?
AnaptysBio, Inc. - Common Stock trades under the ticker ANAB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is AnaptysBio, Inc. - Common Stock stock going up?
ANAB has changed by +12.18% over the last week, +23.25% over the last month, and +98.32% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was AnaptysBio, Inc. - Common Stock net income for the last quarter?
AnaptysBio, Inc. - Common Stock reported net income of -52.88 M for the last quarter. The previous quarter showed 49.61 M, which means net income changed by -206.59%.
How many employees does AnaptysBio, Inc. - Common Stock have?
As of the latest available data, AnaptysBio, Inc. - Common Stock has 104 employees. Workforce size can provide additional context about the company's scale and operations.
What is AnaptysBio, Inc. - Common Stock EBITDA?
AnaptysBio, Inc. - Common Stock EBITDA is -34.51 M, and its EBITDA margin is -135.03%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy AnaptysBio, Inc. - Common Stock stock?
You can buy AnaptysBio, Inc. - Common Stock (ANAB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in AnaptysBio, Inc. - Common Stock stock?
Investing in AnaptysBio, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ANAB chart and related analysis on metatrader.com as part of your research.